ArticleThe Journal of antimicrobial chemotherapy2017

Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB.

Christopher Vinnard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.